Michela Garofalo

Cancer Research UK — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

40h-index8.6kcitations128works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MicroRNA in disease regulation(64), Cancer-related molecular mechanisms research(40), RNA modifications and cancer(37), Circular RNAs in diseases(34), RNA Research and Splicing(18)

Publications128 total

Author Correction: Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells
Scientific Reports·2025Open Access
Editorial Expression of Concern: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
Oncogene·2024Open Access
Preliminary insights into RNA in CSF of pediatric SMA patients after 6 months of nusinersen
Biology Direct·2023· 2 citedOpen Access
Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer
Cell Death and Differentiation·2023· 58 citedOpen Access
Supplementary Figure 4 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Table 1 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Table 2 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Figure 5 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Figure 1 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Figure 2 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Figure 1 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Data from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Figure 3 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Figure 6 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Table 3 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Table 3 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Figure 6 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Table 2 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
fullscanofwesternblots.pptx from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
Supplementary Figure 3 from CKAP2L Promotes Non–Small Cell Lung Cancer Progression through Regulation of Transcription Elongation
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Carlo M. Croce(27), Gianpiero Di Leva(18), Giulia Romano(16), Gerolama Condorelli(15), Gerard J. Nuovo(11), Hansjüerg Alder(11), Cristian Taccioli(9), Stefano Volinia(9), Ciro Zanca(9), Pierluigi Gasparini(7), Cristina Quintavalle(7), Lei Shi(7), Mario Acunzo(6), Young-Jun Jeon(6), Peter Magee(6), Justin Middleton(6), Apollinaire Ngankeu(5), Margherita Iaboni(5), Mariarosaria Incoronato(5), Alessandro Laganà(5)